Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | RHOD |
| Upstream (Parents) |
|---|
| (<<) ARSA → RHOD |
| (<<) BAD → RHOD |
| (<<) CAV1 → RHOD |
| (<<) CBS → RHOD |
| (<<) DAZAP2 → RHOD |
| (<<) FNDC4 → RHOD |
| (<<) HSD11B1 → RHOD |
| (<<) HSD17B2 → RHOD |
| (<<) IGFBP4 → RHOD |
| (<<) LRP5 → RHOD |
| (<<) NFKB1 → RHOD |
| (<<) NNMT → RHOD |
| (<<) ORM1 → RHOD |
| (<<) RDX → RHOD |
| (<<) SAA4 → RHOD |
| (<<) SH3TC1 → RHOD |
| (<<) TFPI2 → RHOD |
| (<<) TSPAN3 → RHOD |
| Downstream (Children) |
|---|
| RHOD → ANGPTL4 (>>) |
| RHOD → EPHB6 (>>) |
| RHOD → ICAM2 (>>) |
| RHOD → IGFBP2 (>>) |
| RHOD → KPNA1 (>>) |
| RHOD → PIK3C2B (>>) |
| RHOD → PLD1 (>>) |
| RHOD → RBP1 (>>) |
| RHOD → RPS6KA3 (>>) |
| RHOD → SIGLEC15 (>>) |
| RHOD → VPS28 (>>) |
